Innovation Trends in Schizophrenia Drugs Industry: Market Outlook 2025-2033
The global schizophrenia drugs market is booming, projected to reach $28B+ by 2033, driven by rising prevalence, new therapies, and improved diagnosis. Explore market trends, leading companies (Eli Lilly, Pfizer, Abbvie), and regional insights in this comprehensive analysis.